Use of SGLT2 Inhibitors Continues to Expand for the Treatment of Chronic Kidney Disease, with Eli Lilly/Boehringer Ingelheim’s Jardiance Making Significant Strides Following Label Expansion
January 03, 2024 16:13 ET
|
Spherix Global Insights
EXTON, PA, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Since 2019, audited records of chronic kidney disease (CKD) non-dialysis patients has revealed an ongoing, annual uptick in the proportion of...
Arch Biopartners Receives Approval from Ethics Committee in Turkey to Proceed with Phase II Cardiac Surgery Associated-Acute Kidney Injury Trial for LSALT Peptide
December 21, 2023 07:30 ET
|
Arch Biopartners
TORONTO, Dec. 21, 2023 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today that it received approval in Turkey from the Kocaeli...
MC2 Therapeutics Announces Completion of Enrollment in MC2-25 Ph2 Chronic Kidney Disease-associated Pruritus Trial
December 07, 2023 07:00 ET
|
MC2 Therapeutics
MC2 Therapeutics Announces Completion of Enrollment in MC2-25 Ph2 Chronic Kidney Disease-associated Pruritus Trial MC2-25 CKD is a first-in-class drug candidate and a potential breakthrough in the...
Arch Biopartners Submits Application to the Turkish Ministry of Health to Conduct a Phase II Cardiac Surgery Associated-Acute Kidney Injury Trial for LSALT Peptide
September 22, 2023 07:00 ET
|
Arch Biopartners
TORONTO, Sept. 22, 2023 (GLOBE NEWSWIRE) -- Arch Biopartners Inc., (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced that it has submitted applications to the Ministry of...
ZyVersa Therapeutics Announces Research Published in The Journal of Clinical Investigation Reinforcing IC 100’s Rationale for Inhibiting ASC Specks to Attenuate Spread of Inflammation into Surrounding Tissues
September 22, 2023 06:35 ET
|
ZyVersa Therapeutics
Patients with chronic kidney disease (“CKD”) exhibit chronic systemic inflammation characterized by increased circulating levels of IL-1β, IL-6, and CRP.This study demonstrated that CKD-induced IL-1β...
Diverse Segmentation Shapes Global Artificial Kidney Market: Device Types, Dialysis Methods, and End-Users Influence Growth Trends
September 11, 2023 05:48 ET
|
Research and Markets
Dublin, Sept. 11, 2023 (GLOBE NEWSWIRE) -- The "Global Artificial Kidney Market 2023-2030" report has been added to ResearchAndMarkets.com's offering. The global artificial kidney market is set...
Dialysis Market Size is projected to reach USD 147.65 billion by 2030, growing at a CAGR of 5.10%: Straits Research
August 28, 2023 11:30 ET
|
Straits Research
New York, United States, Aug. 28, 2023 (GLOBE NEWSWIRE) -- The primary function of the kidney is to eliminate excess fluid and waste from circulation. When the kidneys are not functioning properly,...
Acute Kidney Injury Treatment Market to reach USD 3.0 billion by 2031, expanding at a CAGR of 7.5%: TMR Report
August 11, 2023 07:00 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 11, 2023 (GLOBE NEWSWIRE) -- The global acute kidney injury treatment market is projected to flourish at a CAGR of 7.5% from 2022 to 2031. As per the report...
Healthmap Solutions Announces Kidney Health Management Program Partnership with Triple-S Management Corporation
August 08, 2023 08:00 ET
|
Healthmap Solutions
TAMPA, Fla., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Healthmap Solutions, Inc. (Healthmap), an NCQA-accredited Kidney Population Health Management company, announced its partnership today with Triple-S...
Chronic Kidney Disease Nutritional Supplement Market to Exceed USD 5.0 Bn by 2031 with CAGR of 4.3%: TMR Study
August 01, 2023 11:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, Aug. 01, 2023 (GLOBE NEWSWIRE) -- The global chronic kidney disease nutritional supplement market was valued at US$ 3.3 Bn in 2021, and it is projected to expand...